EDITORIAL

 
DEAR FRIENDS,
 
I am delighted to write the introductory note for our next congress edition scheduled for September 30th and October 1st, 2022.

This new edition, the 9th one, will be with no doubt, even richer, surprising and more user-friendly than the previous one, which, I believe, was very much appreciated.

To stick to this dynamic, we have chosen again the Palais des Congrès in Toulon to welcome you.

The scientific topics will also be open to our fellow radiologists and pathologists for dedicated sessions and even more interactions.

We are of course maintaining our classic uro-oncology sections with the aim to summarize and open the discussion on novelties that are constantly appearing in our recommendations.

We will have a few surprises, very exceptional guests, and always the will to welcome and share 48 brilliant hours with all of you.

Olivier Alenda and I are looking forward to building this meeting for you.

 
Dr Jean-François BERDAH
Hospital center | Ajaccio

 

berdah_edited.jpg
 

PRESS RELEASES

 
congres.png

EDITORIAL

WELCOME TO TOULON
 
Located around one of the most beautiful harbors in Europe and under a faithful sun, this city represents a real regional crossroads, an alternative to the Bouches du Rhône and French Riviera, in the heart of Provence Alps French Riviera region.
We wish to maintain this link in order to discuss our practices while relying on news and knowledge updates in onco-urology thanks to feedback from various congresses.

It is therefore an opportunity to enjoy a moment of friendliness at the heart of the scientific debate.
This annual meeting is simply defined as an event that combines pleasure with high practicality.
 
Dr Olivier ALENDA

slide26.jpg

SUPERIORITY OF IMMUNOTHERAPY COMBOS

Confirmation of superiority of immunotherapy + anti-VEGF combos in first-line therapy for metastatic renal cell carcinoma regardless of prognostic group.

WORKS & PUBLICATIONS OF INTEREST

In the past year (and the past decade has offered us some major medical-surgical scoops in onco-urology), we have been able to note numerous works and publications which are already changing or will change our practices...

STAY INFORMED WITH OUR NEWSLETTER

THANK YOU FOR YOUR SUBSCRIPTION